ulixertinib,bvd-523
biomed valley discoveries
['ulixertinib', 'match study']
#asco22: poster at molecularly targeted agents and tumor biology session shows results of -pediatric match study of ulixertinib in patients with tumors with mapk pathway alterations: 5:30 pm et, 
National #biomedical #research resource w/ focus on #cancer, #AIDS, & #infectious diseases. Currently operated by Leidos Biomedical Research for @theNCI.